MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Cognitive Outcomes and Neuroimages Associated With Anesthesia-Related EEG Signatures

Active, not recruiting

Conditions: General Anesthesia
Elderly

First Posted Date: 2018-02-22

Last Posted Date: 2023-08-01

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 24

Registration Number: NCT03442179

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Phenotyping Asthma for Bronchial Thermoplasty

Recruiting

Conditions: Severe Asthma

First Posted Date: 2018-02-15

Last Posted Date: 2024-05-29

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 50

Registration Number: NCT03435237

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis

Phase 3

Completed

Conditions: Septic Shock

Interventions: Drug: Early Vasopressors
Other: Early Fluids

First Posted Date: 2018-02-15

Last Posted Date: 2023-07-06

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 1563

Registration Number: NCT03434028

Locations: 🇺🇸
Cleveland Clinic Foundation, Cleveland, Ohio, United States
🇺🇸
Ohio State University Wexner Medical Center, Columbus, Ohio, United States
🇺🇸
Temple University Hospital, Philadelphia, Pennsylvania, United States

and more 46 locations

Inpatient Enrollment of Patient Portal App

Not Applicable

Completed

Conditions: Orthopedic Disorder

Interventions: Other: Patient Gateway

First Posted Date: 2018-02-13

Last Posted Date: 2022-11-18

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 232

Registration Number: NCT03431259

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

A Pilot Study of Buspirone for the Treatment of Anxiety in Youth With Autism Spectrum Disorders

Phase 2

Not yet recruiting

Conditions: Autism Spectrum Disorder
Anxiety

Interventions: Drug: Buspirone

First Posted Date: 2018-02-13

Last Posted Date: 2024-07-10

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 15

Registration Number: NCT03432065

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Ruxolitinib Pre-, During- and Post-HSCT for Patients with Primary or Secondary Myelofibrosis.

Phase 2

Active, not recruiting

Conditions: Myelofibrosis

Interventions: Drug: Ruxolitinib

First Posted Date: 2018-02-09

Last Posted Date: 2024-11-20

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 44

Registration Number: NCT03427866

Locations: 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States
🇺🇸
Washington University, Saint Louis, Missouri, United States
🇺🇸
The Ohio State University Wexner Medical Center, Columbus, Ohio, United States

and more 2 locations

Depression and Body Image Distress Following Mastectomy With Reconstruction

Completed

Conditions: Breast Cancer
BRCA2 Mutation
BRCA1 Mutation

Interventions: Other: Psychosocial variables

First Posted Date: 2018-02-09

Last Posted Date: 2021-08-06

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 51

Registration Number: NCT03428399

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Pilot Study for Zoledronic Acid to Prevent Bone Loss After Bariatric Surgery

Phase 4

Completed

Conditions: Bariatric Surgery Candidate

Interventions: Drug: Zoledronic Acid
Dietary Supplement: Calcium citrate + vitamin D
Dietary Supplement: Vitamin D3

First Posted Date: 2018-02-06

Last Posted Date: 2021-04-29

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 6

Registration Number: NCT03424239

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Functional MRI of the Lower Extremities

Not Applicable

Conditions: Peripheral Arterial Disease

Interventions: Behavioral: Supervised exercise therapy

First Posted Date: 2018-02-06

Last Posted Date: 2020-09-16

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 90

Registration Number: NCT03423316

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Fecal Microbiota Transplant As Treatment of Hepatic Encephalopathy

Phase 2

Active, not recruiting

Conditions: Hepatic Encephalopathy

Interventions: Drug: Fecal Microbiota Transplant (FMT) oral capsules
Drug: Placebo oral capsule

First Posted Date: 2018-02-05

Last Posted Date: 2024-12-19

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 30

Registration Number: NCT03420482

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy